Liquid Chromatography for Biopharmaceuticals Market by Technique (High-Pressure Liquid Chromatography (HPLC), Low-Pressure Liquid Chromatography (LPLC), Ultra-High-Pressure Liquid Chromatography (UHPLC)/Ultra-Performance Liquid Chromatography (UPLC), Fast Protein Liquid Chromatography (FPLC)), Type (Instruments, Consumables, Software & Accessories], End User [Pharmaceutical Companies, Academics and Research Institutes, Contract Research Organizations] – Global Outlook & Forecast 2022-2030

GR - 342285 Category: Analytical and Scientific Instrumentation

Number of pages: 100-120 | Report Format: PDF | Published date: 15 July, 2022

Historical Years – 2018 & 2019 | Base Year – 2020 | Forecasted Years – 2021 to 2031

Report Overview

The global liquid chromatography for biopharmaceuticals market was pegged at ~US$ 6,330.1 in 2021 and is expected to witness a CAGR of ~5.7% during the forecast period.

Market Fundamentals

Liquid chromatography is an analytical tool, widely used in the pharmaceutical industry. The technique is used to separate the individual component from a certain sample. It is mainly used in biopharmaceuticals for the purification, identification, and separation of various compounds. Liquid chromatography comes in various techniques like ion exchange, affinity, and high-pressure liquid chromatography. Since biopharmaceuticals are derived from living cells, manufacturing involves complex procedures. This procedure may cause some impurities. Thus, liquid chromatography is used to ensure the efficacy and safety of the final product.

[6454334]

Market Dynamics

The global liquid chromatography for the biopharmaceuticals market is mainly driven by increasing pharmaceutical R&D spending, the growing importance of HPLC tests in drug approvals, and the rising application of chromatography in the purification of monoclonal antibodies. Furthermore, the growing popularity of coupled analytical techniques is also likely to play a critical role in contributing to the growth of the market globally. However, the high cost of equipment and dearth of skilled professionals is likely to restrain market growth to a certain extent.

Market Ecosystem

The global liquid chromatography for biopharmaceuticals market has been analyzed from four perspectives: Technique, Type, End-User, and Region.

Liquid Chromatography for Biopharmaceuticals Market by Technique

The global liquid chromatography for biopharmaceuticals market has been segmented into high-pressure liquid chromatography (HPLC), low-pressure liquid chromatography (LPLC), ultra-high pressure liquid chromatography (UHPLC)/ultra-high pressure liquid chromatography (UPLC), and fast protein liquid chromatography (FPLC). Over the past few decades, high-performance liquid chromatography (HPLC) solutions and inputs have rapidly advanced with the development of biotherapeutics. HPLC coupled with mass spectrometry is commonly used characterization of biopharmaceuticals during drug development.

Liquid Chromatography for Biopharmaceuticals Market by Type

[534344]

The global liquid chromatography for biopharmaceuticals market has been segmented into instruments, consumables, and software & accessories, based on type. Currently, the instruments segment is estimated to capture the largest revenue share in the global liquid chromatography for biopharmaceuticals market. The significant expense of instruments essentially adds to the prevailing place of this portion in the worldwide market. Increasingly more end clients are selecting the novel strategy instruments, for example, UPLC and MS gadgets which are additionally credited to the high-income portion of this fragment.

Liquid Chromatography for Biopharmaceuticals Market by End User

The global liquid chromatography for biopharmaceuticals market has been segmented into pharmaceutical companies, academics & research institutes, and contract research organizations (CROs). The increased demand for biopharmaceuticals to avoid the side effects linked with the usage of small molecules and increased investment associated with R&D have contributed to the growth of liquid chromatography for biopharmaceutical market.

Liquid Chromatography for Biopharmaceuticals Market by Region

Based on region, the global liquid chromatography for biopharmaceuticals market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). In terms of revenue, North America dominates the worldwide liquid chromatography market for biopharmaceuticals. Some of the biggest businesses producing biopharmaceuticals and laboratory equipment are in this area. The main drivers of this market in the region are the rising incidence of chronic diseases in North America and rising U.S. investment in the development of biopharmaceuticals. The United States is acknowledged as the global leader in life sciences innovation, and it participates in international capital investments in biopharmaceutical start-ups. Many biotech and pharmaceutical businesses in the United States worked to create effective COVID-19 medicines during the pandemic, which helped to expand the market at the time. the increasing prevalence of chronic illnesses.

Adding to this, liquid chromatography for the biopharmaceuticals market is predicted to have lucrative growth prospects due to the rising healthcare spending in the Asia Pacific region. The Indian market is characterized by rising stakeholder investment and expanding domestic government policy backing. Several research and manufacturing organizations are attracted to pipeline medication development and marketing because of the recognition and prominence that many biotech businesses and CROs are achieving on the global markets.

Competitive Landscape

Some of the prominent players operating in the liquid chromatography for biopharmaceuticals market are

Thermo Fisher Scientific Inc
Agilent Technologies Inc
PerkinElmer Inc
Merck KGaA
Waters Corporation
Bio-Rad Laboratories, Inc
Tosoh Bioscience LLC
Metrohm AG
Danaher Corporation
Shimadzu Corporation
Among others

Strategic Developments

Agilent announced the launch of three InfinityLab Bio Systems specifically developed to meet the needs of the biopharma industry. The new InfinityLab Bio LC portfolio is designed to help labs by providing a future-proof, universal LC solution that delivers InfinityLab LC performance with additional bioanalysis capability and even higher durability in harsh analytical conditions.
PerkinElmer collaborated with Scitara, a laboratory digital transformation innovator. This move is aimed to support the integration of the PerkinElmer informatics platform with laboratory instruments, applications, and resources via the Scitara Scientific Integration Platform™ SIP™

Report Scope

Report Attribute	Details
Market size value in 2021	USD 6,330.1 million
Revenue forecast in 2030	USD 10,697.4 million
Growth Rate	CAGR of ~5.7% from 2022 to 2030
Base year for estimation	2021
Forecast period	2022-2030
Segments covered	Technique, Type, End User
Regional scope	North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Frequently Asked Questions About This Report

arrow_forward The global liquid chromatography for biopharmaceuticals market was anticipated to clock US$ 6,330.1 in 2021

arrow_forward The liquid chromatography for biopharmaceuticals market is projected to reach US$ 10,697.4 billion by 2030

arrow_forward The global liquid chromatography for biopharmaceuticals market is mainly driven by the growing use of chromatography in the purification of monoclonal antibodies

arrow_forward Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Merck KGaA, Waters Corporation, Bio-Rad Laboratories, Inc., Tosoh Bioscience LLC, Metrohm AG, Danaher Corporation, Shimadzu Corporation

arrow_forward The growth rate of liquid chromatography for biopharmaceuticals market is CAGR of ~5.7% between 2022-2030

arrow_forward North America held the largest market share of the global liquid chromatography for biopharmaceuticals market

Chapter 1 Market Introduction

1.1 Market Ecosystem

1.2 Market Snapshot

1.3 Timeline Under Consideration

1.4 Currency Referred

Chapter 2 Research Methodology

2.1 Research Approach

2.2 Data Collection Methodology

2.3 Data Sources

2.3.1 Secondary Sources

2.3.2 Primary Sources

2.4 Market Estimation Approach

2.4.1 Bottom Up

2.4.2 Top Down

2.5 Market forecasting Model

2.6 Limitations and Assumptions

Chapter 3 Premium Insights

3.1 Current Market Trends (COVID-19 Pandemic Perspective)

3.2 Key Players and Competitive Positioning (2021)

Chapter 4 Market Dynamics

4.1 Overview

4.2 Drivers

4.2.1 Rapid Growth of Biopharmaceuticals Industry

4.2.2 Rising Popularity of Hyphenated Techniques

4.3 Challenges

4.3.1 Complicated Novel Technologies Restricting Mainstream Usage

4.3.2 Insufficient Penetration to Small Biopharmaceutical Companies

4.4 Opportunities

4.4.1 Use of Intelligent Database and Predictive Analysis

4.4.2 Technological Innovation in Bioprocessing

Chapter 5 HPLC and UPLC Systems Market Volume

Chapter 6 Global Liquid Chromatography for Biopharmaceuticals Market forecast and Analysis to 2030, By Technique

6.1 Overview

6.2 High-Pressure Liquid Chromatography (HPLC)

6.3 Low-Pressure Liquid Chromatography (LPLC)

6.4 Ultra-High-Pressure Liquid Chromatography (UHPLC)/Ultra-Per formance Liquid Chromatography (UPLC)

6.5 Fast Protein Liquid Chromatography (FPLC)

Chapter 7 Global Liquid Chromatography for Biopharmaceuticals Market forecast and Analysis to 2030, By Product Type

7.1 Overview

7.2 Instruments

7.3 Consumables

7.4 Software & Accessories

Chapter 8 Global Liquid Chromatography for Biopharmaceuticals Market forecast and Analysis to 2030, By End User

8.1 Overview

8.2 Pharmaceutical Companies

8.3 Academics and Research Institutes

8.4 Contract Research Organizations (CROs)

Chapter 9 Global Liquid Chromatography for Biopharmaceuticals Market forecast and Analysis to 2030, by Region

9.1 Overview

9.2 North America

9.3 Europe

9.4 Asia Pacific

9.5 Rest of the World

Chapter 10 Company Profiles

10.1 Thermo Fisher Scientific Inc.

10.1.1 Company Snapshot

10.1.2 Product Portfolio

10.1.3 Financial Overview

10.1.4 Strategic Developments

10.2 Agilent Technologies Inc.

10.2.1 Company Snapshot

10.2.2 Product Portfolio

10.2.3 Financial Overview

10.2.4 Strategic Development

10.3 PerkinElmer Inc.

10.3.1 Company Snapshot

10.3.2 Product Portfolio

10.3.3 Financial Overview

10.3.4 Strategic Developments

10.4 Merck KGaA

10.4.1 Company Snapshot

10.4.2 Product Portfolio

10.4.3 Financial Overview

10.4.4 Strategic Developments

10.5 Waters Corporation

10.5.1 Company Snapshot

10.5.2 Product Portfolio

10.5.3 Financial Overview

10.5.4 Strategic Developments

10.6 Bio-Rad Laboratories, Inc.

10.6.1 Company Snapshot

10.6.2 Product Portfolio

10.6.3 Financial Overview

10.6.4 Strategic Developments

10.7 Tosoh Bioscience LLC

10.7.1 Company Snapshot

10.7.2 Product Portfolio

10.7.3 Financial Overview

10.7.4 Strategic Developments

10.8 Metrohm AG

10.8.1 Company Snapshot

10.8.2 Product Portfolio

10.8.3 Financial Overview

10.8.4 Strategic Developments

10.9 Danaher Corporation

10.9.1 Company Snapshot

10.9.2 Product Portfolio

10.9.3 Financial Overview

10.9.4 Strategic Developments

10.10 Shimadzu Corporation

10.10.1 Company Snapshot

10.10.2 Product Portfolio

10.10.3 Financial Overview

10.10.4 Strategic Developments

List of Tables

TABLE 1 HPLC & UPLC Systems Sold, by Top 4 Players, 2017 – 2021 (Units)

TABLE 2 HPLC and UPLC Systems Sold, by Application, 2017 - 2021 (Units)

TABLE 3 SEC Columns Volume (HPLC & UPLC), 2017 - 2021 (Units)

TABLE 4 Affinity Columns Volume (HPLC & UPLC), 2017 - 2021 (Units)

TABLE 5 mAb Columns Volume (HPLC & UPLC), 2017 - 2021 (Units)

TABLE 6 Global Liquid Chromatography for Biopharmaceuticals Market, By Technique, 2020 – 2030 ($ Million)

TABLE 7 Global HPLC for Biopharmaceuticals Market, By Region, 2020 – 2030 ($ Million)

TABLE 8 Global LPLC for Biopharmaceuticals Market, By Region, 2020 – 2030 ($ Million)

TABLE 9 Global UHPLC/UPLC for Biopharmaceuticals Market, By Region, 2020 – 2030 ($ Million)

TABLE 10 Global FPLC for Biopharmaceuticals Market, By Region, 2020 – 2030 ($ Million)

TABLE 11 Global Liquid Chromatography for Biopharmaceuticals Market, By Product Type, 2022–2030 ($ Million)

TABLE 12 Global Instruments Market, By Region, 2020 – 2030 ($ Million)

TABLE 13 Global Consumables Market, By Region, 2020 – 2030 ($ Million)

TABLE 14 Global Software & Accessories Market, By Region, 2020 – 2030 ($ Million)

TABLE 15 Global Liquid Chromatography for Biopharmaceuticals Market, By End User, 2020–2030 (US$ Million)

TABLE 16 Global Pharmaceuticals Market, By Region, 2020 – 2030 ($ Million)

TABLE 17 Global Academics And Research Institutes Market, By Region, 2020 – 2030 ($ Million)

TABLE 18 Global Contract Research Organizations Market, By Region, 2020 – 2030 ($ Million)

TABLE 19 Global Liquid Chromatography for Biopharmaceuticals Market, by Region, 2020 – 2030 ($ Million)

TABLE 20 North America Liquid Chromatography for Biopharmaceuticals Market, By Country, 2020 – 2030 ($ Million)

TABLE 21 North America Liquid Chromatography for Biopharmaceuticals Market, By Technique, 2020 – 2030 ($ Million)

TABLE 22 North America Liquid Chromatography for Biopharmaceuticals Market, By Product Type, 2020 – 2030 ($ Million)

TABLE 23 North America Liquid Chromatography for Biopharmaceuticals Market, By End User, 2020 – 2030 ($ Million)

TABLE 24 Europe Liquid Chromatography for Biopharmaceuticals Market, By Country, 2020 – 2030 ($ Million)

TABLE 25 Europe Liquid Chromatography for Biopharmaceuticals Market, By Technique, 2020 – 2030 ($ Million)

TABLE 26 Europe Liquid Chromatography for Biopharmaceuticals Market, By Product Type, 2020 – 2030 ($ Million)

TABLE 27 Europe Liquid Chromatography for Biopharmaceuticals Market, By End User, 2020 – 2030 ($ Million)

TABLE 28 Asia Pacific Liquid Chromatography for Biopharmaceuticals Market, By Country, 2020 – 2030 ($ Million)

TABLE 29 Asia Pacific Liquid Chromatography for Biopharmaceuticals Market, By Technique, 2020 – 2030 ($ Million)

TABLE 30 Asia Pacific Liquid Chromatography for Biopharmaceuticals Market, By Product Type, 2020 – 2030 ($ Million)

TABLE 31 Asia Pacific Liquid Chromatography for Biopharmaceuticals Market, By End User, 2020 – 2030 ($ Million)

TABLE 32 Rest of the World Liquid Chromatography for Biopharmaceuticals Market, By Country, 2020 – 2030 ($ Million)

TABLE 33 Rest of the World Liquid Chromatography for Biopharmaceuticals Market, By Technique, 2020 – 2030 ($ Million)

TABLE 34 Rest of the World Liquid Chromatography for Biopharmaceuticals Market, By Product Type, 2020 – 2030 ($ Million)

TABLE 35 Rest of the World Liquid Chromatography for Biopharmaceuticals Market, By End User, 2020 – 2030 ($ Million)

List of Figures

FIG. 1 Liquid Chromatography for Biopharmaceuticals Market EcoSystem

FIG. 2 Snapshot of Global Liquid Chromatography for Biopharmaceuticals Market, 2020-2030

FIG. 3 Global Liquid Chromatography for Biopharmaceuticals Market: COVID-19 Pandemic Impact Assessment

FIG. 4 Global Liquid Chromatography for Biopharmaceuticals Market: Key Players & Competitive Positioning (2021)

FIG. 5 Liquid Chromatography for Biopharmaceuticals Market Dynamics

FIG. 6 Global Liquid Chromatography for Biopharmaceuticals Market – By Technique, 2021 & 2030 (% Share)

FIG. 7 Global High-Pressure Liquid Chromatography Market, 2020-2030 ($ Million)

FIG. 8 Global HPLC for Biopharmaceuticals Market – By Region, 2021 & 2030 (% Share)

FIG. 9 Global Low-Pressure Liquid Chromatography Market, 2020-2030 ($ Million)

FIG. 10 Global LPLC for Biopharmaceuticals Market – By Region, 2021 & 2030 (% Share)

FIG. 11 Global UHPLC/UPLC for Biopharmaceuticals Market, 2020-2030 ($ Million)

FIG. 12 Global UHPLC/UPLC for Biopharmaceuticals Market – By Region, 2021 & 2030 (% Share)

FIG. 13 Global FPLC for Biopharmaceuticals Market, 2020-2030 ($ Million)

FIG. 14 Global FPLC for Biopharmaceuticals Market – By Region, 2021 & 2030 (% Share)

FIG. 15 Global Liquid Chromatography for Biopharmaceuticals Market – By Product, 2021 & 2030 (% Share)

FIG. 16 Global Liquid Chromatography for Biopharmaceuticals Market, By Instruments, 2020-2030 ($ Million)

FIG. 17 Global Instruments Market – By Region, 2021 & 2030 (% Share)

FIG. 18 Global Liquid Chromatography for Biopharmaceuticals Market, By Consumables, 2020-2030 ($ Million)

FIG. 19 Global Consumables Market – By Region, 2021 & 2030 (% Share)

FIG. 20 Global Liquid Chromatography for Biopharmaceuticals Market, By Software & Accessories, 2020-2030 ($ Million)

FIG. 21 Global Software & Accessories Market – By Region, 2021 & 2030 (% Share)

FIG. 22 Global Liquid Chromatography for Biopharmaceuticals Market – By End User, 2021 & 2030 (% Share)

FIG. 23 Global Liquid Chromatography for Biopharmaceuticals Market, Pharmaceutical Companies, 2020-2030 ($ Million)

FIG. 24 Global Pharmaceutical Companies Market – By Region, 2021 & 2030 (% Share)

FIG. 25 Global Liquid Chromatography for Biopharmaceuticals Market, By Academics and Research Institutes, 2020-2030 ($ Million)

FIG. 26 Global Academics And Research Institutes Market – By Region, 2021 & 2030 (% Share)

FIG. 27 Global Liquid Chromatography for Biopharmaceuticals Market, By CROs 2020-2030 ($ Million)

FIG. 28 Global Contract Research Organizations Market – By Region, 2021 & 2030 (% Share)

FIG. 29 Global Liquid Chromatography for Biopharmaceuticals Market – By Region, 2021 & 2030 (% Share)

FIG. 30 North America Liquid Chromatography for Biopharmaceuticals Market, 2020-2030 ($ Million)

FIG. 31 North America Liquid Chromatography for Biopharmaceuticals Market – By Technique, 2021 & 2030 (% Share)

FIG. 32 North America Liquid Chromatography for Biopharmaceuticals Market – By Product Type, 2021 & 2030 (% Share)

FIG. 33 North America Liquid Chromatography for Biopharmaceuticals Market – By End User, 2021 & 2030 (% Share)

FIG. 34 Europe Liquid Chromatography for Biopharmaceuticals Market, 2020-2030 ($ Million)

FIG. 35 Europe Liquid Chromatography for Biopharmaceuticals Market – By Technique, 2021 & 2030 (% Share)

FIG. 36 Europe Liquid Chromatography for Biopharmaceuticals Market – By Product Type, 2021 & 2030 (% Share)

FIG. 37 Europe Liquid Chromatography for Biopharmaceuticals Market – By End User, 2021 & 2030 (% Share)

FIG. 38 Asia Pacific Liquid Chromatography for Biopharmaceuticals Market, 2020-2030 ($ Million)

FIG. 39 Asia Pacific Liquid Chromatography for Biopharmaceuticals Market – By Technique, 2021 & 2030 (% Share)

FIG. 40 Asia Pacific Liquid Chromatography for Biopharmaceuticals Market – By Product Type, 2021 & 2030 (% Share)

FIG. 41 Asia Pacific Liquid Chromatography for Biopharmaceuticals Market – By End User, 2021 & 2030 (% Share)

FIG. 42 Rest of the World Liquid Chromatography for Biopharmaceuticals Market, 2020-2030 ($ Million)

FIG. 43 Rest of the World Liquid Chromatography for Biopharmaceuticals Market – By Technique, 2021 & 2030 (% Share)

FIG. 44 Rest of the World Liquid Chromatography for Biopharmaceuticals Market – By Product Type, 2021 & 2030 (% Share)

FIG. 45 Rest of the World Liquid Chromatography for Biopharmaceuticals Market – By End User, 2021 & 2030 (% Share)

Single User License

Five Users License

Enterprise User License

Data Pack License

$4,750.00

Growth+Reports can now be customized as per client’s needs through GRG Health’s primary research and knowledge services capabilities

GRG Health’s unique GrowthMIX approach and robust research methodology helps us deliver unique & meaningful insights to our clients and uncover trends that won’t meet the standard approach

Ask For Customization Check Discount Speak To Analyst Inquire Before Buying

Report Overview

Report Scope

Frequently Asked Questions About This Report

Table of Contents